M&A MVP: Latham & Watkins' Charles Ruck
For his work this year on a slew of complex life sciences and technology deals including Watson Pharmaceuticals Inc.'s $5.65 billion acquisition of Actavis Group, Latham & Watkins LLP's Charles K....To view the full article, register now.
Already a subscriber? Click here to view full article